Pfizer has escalated its fight for obesity biotech Metsera by filing suit against both Metsera and Novo Nordisk in the Delaware Court of Chancery on October 31.The litigation challenges Novo’s bombshell $8.5 billion offer as legally superior to Pfizer’s original $7.2 billion deal announced in September.Metsera’s board declared Novo’s bid…
Canadian Prime Minister Mark Carney publicly confirmed on Saturday that he has apologized to US President Donald Trump for…
In his first public remarks since securing a fragile trade truce with the United States, Chinese President Xi Jinping…
Air India is seeking an urgent financial infusion of at least $1.1 billion from its owners, Tata Sons Pvt.…
Japan’s largest power generation company, Jera Co., is stepping up its liquefied natural gas (LNG) investments across Southeast Asia…
In his first public comments on Amazon’s latest round of mass layoffs, CEO Andy Jassy offered a surprising justification…
European stocks opened lower on Friday as investors navigated a complex mix of signals, weighing a cautious stance from…
China’s manufacturing sector slipped further into contraction in October, underscoring the pressure on the world’s second largest economy as…
Netflix is weighing a bid for Warner Bros Discovery’s studio and streaming assets, marking what could be one of…